A study to assess the safety and tolerability of AZD1390 given with radiation therapy in patients with brain cancer

Trial Identifier: D6940C00002
Sponsor: AstraZeneca
Start Date: April 2018
Primary Completion Date: September 2026
Study Completion Date: September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GB Cambridge, GB, CB2 0QQ
GB Glasgow, GB, G12 0YN
GB Leeds, GB, LS9 7TF
JP Chuo-ku, JP, 104-0045
JP Hidaka-shi, JP, 350-1298
JP Kyoto-shi, JP, 606-8507
US, MA Boston, MA, US, 02114
US, MA Boston, MA, US, 02215
US, NY New York, NY, US, 10065
US, PA Pittsburgh, PA, US, 15232
US, VA Richmond, VA, US, 23298